Practo vs Revvity

Side-by-side comparison of AI visibility scores, market position, and capabilities

Practo logo

Practo

ChallengerHealthcare

Digital Health Platform

India's leading digital health platform — doctor discovery, telemedicine, clinic software, and health plans. FY25 revenue ~₹350-400 Cr; 2026 IPO preparation underway; expanding to UAE and US.

About

Practo is India''s largest digital health platform, providing consumers with doctor discovery, online appointment booking, video consultations, health plans, and diagnostic services. On the B2B side, Practo offers clinic management software used by thousands of healthcare providers across India. Founded in Bengaluru, the company serves a broad population seeking affordable and accessible healthcare, with over 2 lakh (200,000) doctors listed. Practo achieved its first fully profitable quarter in late FY2024 and is on track for sustained profitability, with FY2024–25 revenue estimated at ₹350–400 crore. The company expanded to the UAE in 2025 and launched a U.S. care navigation platform in January 2026, targeting an annualized GMV run-rate of $1B by mid-2026. Practo is preparing for a second-half 2026 IPO in India.

Full profile
Revvity logo

Revvity

LeaderHealthcare Tech

Life Science Tools & Diagnostics

Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.

AI VisibilityBeta
Overall Score
A94
Category Rank
#1 of 1
AI Consensus
72%
Trend
up
Per Platform
ChatGPT
92
Perplexity
99
Gemini
96

About

Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.

Full profile

Key Details

Category
Digital Health Platform
Life Science Tools & Diagnostics
Tier
Challenger
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Revvity
Life Science Tools & Diagnostics

Integrations

Only Revvity
Revvity is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.